Biotech

All Articles

James Wilson leaving behind Penn to launch 2 brand-new biotechs

.After much more than three decades, genetics treatment pioneer James Wilson M.D., Ph.D., is actuall...

3 biotechs make an effort to trump the summer season heat by dropping team

.As biotechs attempt to turn a new webpage in August, a minimum of three companies have actually dro...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Expert financial backing company venBio has actually raised one more half a billion bucks to buy bi...

Otsuka pays $800M for Jnana and also its clinical-stage PKU drug

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Therapies for $800 thousand so the ...

FibroGen lays off 75% people team as asset fails 2 additional tests

.FibroGen is substantially reorganizing its service, laying off 75% of its own U.S. personnel and qu...

Tracon relax full weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has actually determined to unwind operations weeks after an injectable immun...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on stopped working epilepsy medicine, touts FDA operate

.Our company currently understand that Takeda is wishing to locate a course to the FDA for epilepsy ...

VBI Vaccinations files for personal bankruptcy, looks for asset purchase

.Immunology biotech VBI Vaccines is actually drifting dangerously near the point of no return, with ...

Celldex anti-cKIT antibody reduce hives in an additional phase 2 study

.It's hard to muscle in on an area as affordable as immunology, yet Celldex Therapeutics feels that ...